{"DataElement":{"publicId":"2486309","version":"1","preferredName":"Hormone Biomarker Concentration Name","preferredDefinition":"The name of the hormone biomarker concentration.","longName":"HORM_BIOM_CONC_NM","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2486290","version":"1","preferredName":"Hormone Biomarker Concentration Name","preferredDefinition":"The name of the biomarker hormone concentration.","longName":"HORM_BIOM_CONC_NM","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2486287","version":"1","preferredName":"Hormone Biomarker","preferredDefinition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.:Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","longName":"C2315:C16342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone","conceptCode":"C2315","definition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15B8CAAC-1285-3EB6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"ONEDATA","dateModified":"2006-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2931841","version":"1","preferredName":"Concentration Name","preferredDefinition":"A measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.:The words or language units by which a thing is known.","longName":"C41185:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concentration","conceptCode":"C41185","definition":"The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70C03343-1B33-3FCD-E040-BB89AD43759D","latestVersionIndicator":"Yes","beginDate":"2009-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-09","modifiedBy":"ONEDATA","dateModified":"2009-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15B8CAAC-12A7-3EB6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2486306","version":"1","preferredName":"Hormone Biomarker Concentration Name","preferredDefinition":"The name of the hormone biomarker concentration.","longName":"HORM_BIOM_CONC_NM","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Estradiol","valueDescription":"Estradiol","ValueMeaning":{"publicId":"2576827","version":"1","preferredName":"Estradiol","longName":"2576827","preferredDefinition":"Estradiol (E2). beta-estradiol; 17 beta-estradiol; 1,3,5(10)-estratriene-3,17 beta-diol; the most potent naturally occurring estrogen in mammals, formed by the ovary, placenta, testis, and possibly the adrenal cortex; therapeutic indications for estradiol are those typical of an estrogen. alpha-Estradiol, (17 alpha-estradiol), exhibits considerably less biologic activity. Estradiol is used in the treatment of menstrual disorders, menopause problems, etc. SYN estrogenic hormone, oestradiol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estradiol","conceptCode":"C2295","definition":"The most potent form of the naturally occurring steroid sex hormone in humans, produced by ovary, placenta, testis, and in small amount by adrenal cortex. Estradiol binds to a specific intracellular estrogen receptor located in female organs, breasts, hypothalamus and pituitary. The receptor-ligand complex promotes gene expression necessary for the maintenance of fertility and secondary sexual characteristics in females. In addition, estradiol exhibits mild anabolic and metabolic properties, and increases blood coagulability. Estradiol, the principal intracellular human estrogen, is substantially more active at the cellular level than its metabolites, estrone and estriol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F928-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC61FA-9FA1-218F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"Testosterone","valueDescription":"Testosterone","ValueMeaning":{"publicId":"2579543","version":"1","preferredName":"Testosterone","longName":"2579543","preferredDefinition":"(tes-TOS-ter-own) A hormone that promotes the development and maintenance of male sex characteristics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testosterone","conceptCode":"C2299","definition":"A hormone made mainly in the testes (part of the male reproductive system). It is needed to develop and maintain male sex characteristics, such as facial hair, deep voice, and muscle growth. Testosterone may also be made in the laboratory and is used to treat certain medical conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-03C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC61FA-9FB6-218F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"IGF-1","valueDescription":"IGF-1","ValueMeaning":{"publicId":"2579544","version":"1","preferredName":"IGF-1","longName":"2579544","preferredDefinition":"Insulin-like Growth Factor-1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-03C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC71B6-01A8-231F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"IGFBP-3","valueDescription":"IGFBP-3","ValueMeaning":{"publicId":"2579545","version":"1","preferredName":"IGFBP-3","longName":"2579545","preferredDefinition":"Insulin-Like Growth Factor Binding Protein-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-03C6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC71B6-01B4-231F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"SHBG","valueDescription":"SHBG","ValueMeaning":{"publicId":"2579546","version":"1","preferredName":"SHBG","longName":"2579546","preferredDefinition":"Sex Hormone Binding Globulin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-03C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC71B6-01C0-231F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"CRP","valueDescription":"CRP","ValueMeaning":{"publicId":"2579547","version":"1","preferredName":"CRP","longName":"2579547","preferredDefinition":"C-Reactive Protein","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-03C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15BC71B6-01CD-231F-E044-0003BA3F9857","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2006-06-08","deletedIndicator":"No"},{"value":"Estrone","valueDescription":"Estrone","ValueMeaning":{"publicId":"2576306","version":"1","preferredName":"Estrone","longName":"2576306","preferredDefinition":"One of three naturally occuring estrogens synthesized from androstenedione in the adrenal glands and peripheral tissues by aromatization and is the primary estrogen produced after menopause.(NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrone","conceptCode":"C2294","definition":"One of three naturally occurring estrogens synthesized from androstenedione in the adrenal glands and peripheral tissues by aromatization and is the primary estrogen produced after menopause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F71F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"716A994E-EE12-62F4-E040-BB89AD430311","beginDate":"2009-08-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-18","modifiedBy":"ONEDATA","dateModified":"2009-08-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15BC61EE-7632-1C49-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"MAESKEB","dateModified":"2009-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Concentration","type":"Preferred Question Text","description":"Concentration","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"15BC61EE-7647-1C49-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-08","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}